Cargando…

IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate ETV6::RUNX1-positive leukemia cells in preclinical models

Detalles Bibliográficos
Autores principales:	Ågerstam, Helena, Lilljebjörn, Henrik, Rissler, Marianne, Sandén1, Carl, Fioretos, Thoas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890010/ https://www.ncbi.nlm.nih.gov/pubmed/36226493 http://dx.doi.org/10.3324/haematol.2022.281059

Ejemplares similares

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
por: Lilljebjörn, Henrik, et al.
Publicado: (2016)

CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
por: Landberg, Niklas, et al.
Publicado: (2018)

Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia
por: Lundin-Ström, Kristina B., et al.
Publicado: (2018)

Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia
por: Gunnarsson, Rebeqa, et al.
Publicado: (2018)

ETV6-RUNX1 Rearrangement in Tunisian Pediatric B-Lineage Acute Lymphoblastic Leukemia
por: Gmidène, Abir, et al.
Publicado: (2009)

Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia
por: Ellinghaus, E, et al.
Publicado: (2012)

Prevalence of ETV6/RUNX1 Fusion Gene in Pediatric Patients with Acute Lymphoblastic Leukemia in Iran
por: Rahnemoon, Ahmad-Reza, et al.
Publicado: (2013)

Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells
por: Askmyr, Maria, et al.
Publicado: (2017)

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
por: von Palffy, Sofia, et al.
Publicado: (2022)

Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse
por: Sun, Congcong, et al.
Publicado: (2017)

CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
por: Blunck, Caroline B., et al.
Publicado: (2019)

The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
por: Østergaard, Anna, et al.
Publicado: (2023)

ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
por: Wang, Yu, et al.
Publicado: (2018)

The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1‐positive acute lymphoblastic leukemia
por: Sun, Congcong, et al.
Publicado: (2019)

Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens
por: Rüchel, Nadine, et al.
Publicado: (2023)

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function
por: Hansen, N, et al.
Publicado: (2013)

Modeling the process of childhood ETV6-RUNX1 B-cell leukemias
por: Rodríguez-Hernández, Guillermo, et al.
Publicado: (2017)

A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
por: von Palffy, Sofia, et al.
Publicado: (2020)

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells
por: Askmyr, M, et al.
Publicado: (2014)

ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis
por: Jakobczyk, Hélène, et al.
Publicado: (2021)

Clonal competition within complex evolutionary hierarchies shapes AML over time
por: Sandén, Carl, et al.
Publicado: (2020)

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group
por: Qiu, Kun-yin, et al.
Publicado: (2021)

Transcriptional profiling demonstrates altered characteristics of CD8 (+) cytotoxic T‐cells and regulatory T‐cells in TP53‐mutated acute myeloid leukemia
por: Abolhalaj, Milad, et al.
Publicado: (2022)

Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states
por: Somasundaram, Rajesh, et al.
Publicado: (2016)

RAG1 co‐expression signature identifies ETV6‐RUNX1‐like B‐cell precursor acute lymphoblastic leukemia in children
por: Chen, Dongfeng, et al.
Publicado: (2021)

Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea
por: Lee, Jae Wook, et al.
Publicado: (2017)

Coexistence of ETV6-RUNX1 and MLL aberration among pediatric acute lymphoblastic leukemia: case reports and a literature review
por: Qiu, Kun-Yin, et al.
Publicado: (2023)

Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia
por: Yang, Minjun, et al.
Publicado: (2019)

The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia
por: Rodríguez-Hernández, Guillermo, et al.
Publicado: (2021)

Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia
por: Ghazavi, Farzaneh, et al.
Publicado: (2016)

Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia
por: Polak, Roel, et al.
Publicado: (2019)

Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia
por: Lee, Jae Wook, et al.
Publicado: (2021)

Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia
por: Brandes, Danielle, et al.
Publicado: (2023)

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
por: Rodriguez-Zabala, Maria, et al.
Publicado: (2023)

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia
por: Sharma, Gunjan, et al.
Publicado: (2021)

RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia
por: Sharma, Gunjan, et al.
Publicado: (2023)

Chromosomal Aberrations in ETV6/RUNX1-positive Childhood Acute Lymphoblastic Leukemia using 244K Oligonucleotide Array Comparative Genomic Hybridization
por: Zakaria, Zubaidah, et al.
Publicado: (2012)

SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia Patients
por: Serafin, Valentina, et al.
Publicado: (2019)

Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia
por: Yu, Weijuan, et al.
Publicado: (2021)

Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/−) leukemia
por: van der Weyden, Louise, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f442h8lnqtj13krpghg1emqv43